Skip to main content
SLU publication database
Research article - Peer-reviewed, 2010

The extracellular domain of Bri2 (ITM2B) binds the ABri peptide (1-23) and amyloid beta-peptide (A beta 1-40): Implications for Bri2 effects on processing of amyloid precursor protein and A beta aggregation

Johansson, Jan; Peng, S

Abstract

In Alzheimer's disease the amyloid beta-peptide (A beta) aggregates in brain tissue and arteries. A beta is proteolytically cleaved out from amyloid precursor protein (APP) by different secretases. Recently, the transmembrane protein ITM2B/Bri2, which is expressed in neurons and associated with familial British and Danish dementia, was shown to inhibit APP processing in transfected cells as well as in transgenic mice. Several mechanisms by which Bri2 can interfere with A beta production and aggregation have been proposed. Herein, we studied recombinant human Bri2 (residues 90-236) containing the extracellular Brichos domain without the ABri23 peptide. Bri2(90-236) binds to ABri23, which suggests that these two parts interact during Bri2 biosynthesis, in line with proposed functions of Brichos domains in other proteins. Moreover, Bri2(90-236) binds A beta 1-40 and inhibits its aggregation and fibril formation. These data suggest a model for how the processing of Bri2 and APP are interrelated. (C) 2009 Elsevier Inc. All rights reserved.

Keywords

Alzheimer's disease; Brichos domain; Bri2; ITM2B; APP; Protein interaction

Published in

Biochemical and Biophysical Research Communications
2010, Volume: 393, number: 3, pages: 356-361
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCE

    SLU Authors

    UKÄ Subject classification

    Biochemistry and Molecular Biology

    Publication Identifiers

    DOI: https://doi.org/10.1016/j.bbrc.2009.12.122

    Permanent link to this page (URI)

    https://res.slu.se/id/publ/48442